News & Analysis on Clinical Trial Services & Contract Research And Development
So far only Switzerland and Israel have asked to be included in the list of countries not required to provide written confirmation that plants making APIs destined for the EU meet the required standards according to an EC statement.
Leading eClinical firms will win market share over the next decade as biopharma firms stick with tools they know, an analyst predicts.
Prosonix aims to develop new treatments for respiratory diseases though an R&D accord formed with Imperial College London (ICL).
SOCMA’s BPTF says new fee laws under the FDA Safety and Innovation Act will improve drug quality and boost US manufacturing sector.
Specialist aerosol CDMO Exemplar Pharma has been issued with a 483 by the US FDA for inadequate process control procedures.